However, the current study shows that expression of the hENT1 gene was not reduced in the development of gemcitabine resistance, and did not correlate with IC50 values of gemcitabine in eight pancreatic cancer cell lines. This evidence concerns the gene SLC29A1 and pancreatic neoplasm.